Science & Enterprise subscription

Follow us on Twitter

  • Statista prepared a chart this week with data from an annual report by the Intellectual Property Owners Association…
    about 29 mins ago
  • New post on Science and Enterprise: Infographic – IBM Leads Again in Patent Awards #Science #Business
    about 30 mins ago
  • An engineering team designed sensors that stick on the skin and form a network with radio-frequency signals to trac…
    about 20 hours ago
  • New post on Science and Enterprise: Skin Sensor Network Tracks Health Functions #Science #Business
    about 20 hours ago
  • A new project examines brain pathologies leading to development of Alzheimer's disease in Americans of Hispanic des…
    about 1 day ago

Please share Science & Enterprise

Diagnostics Start-Up Closes $33.5M Early-Stage Financing

DNA strand (NSF)

(James. J. Caras, National Science Foundation)

Foundation Medicine Inc., a developer of cancer genome diagnostics in Cambridge, Massachusetts, has expanded its early stage financing to $33.5 million, adding new venture investors. The additional financing is expected to help the company continue its research  work on cancer diagnostic tests.

The new funding from Google Ventures and venture capital company Kleiner Perkins Caufield & Byers (KPCB), supplements Foundation Medicine’s initial series A financing, the first round of equity funding after seed capital, from a group led by investment company Third Rock Ventures.

Foundation Medicine was founded last year to devise comprehensive diagnostic tests that analyze relevant tumor genomes and other molecular information in individual patients’ cancers and connect the results to a knowledge base of clinical data to help oncologists personalize treatment. Because patients whose cancers have specific genetic alterations are difficult to recruit in sufficient numbers for clinical trials, the company plans to report test results to physicians through a secure Web site linking genomic data to relevant, publicly available scientific and medical information. Physicians can then recommend cancer treatment approaches tailored to each patient’s molecular subtype.

The company founders — Eric Lander, Todd Golub, Levi Garraway, and Matthew Meyerson — conduct research on genomics at the Broad Institute, Harvard Medical School, Dana-Farber Cancer Institute, and MIT. They also serve on a company advisory committee.

Brook Byers, partner, KPCB, and Krishna Yeshwant, partner, Google Ventures, will join Foundation Medicine’s board of directors.

Read more: Google to Partner with, Finance DNA Sequencing Data Company

*     *     *

Please share Science & Enterprise ...

2 comments to Diagnostics Start-Up Closes $33.5M Early-Stage Financing